Can telemedicine help kids with sickle cell disease get better care?
NCT ID NCT05087303
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether two different telemedicine models could help children with sickle cell disease living in medically underserved areas get better care. Researchers tested the models with 24 families and measured things like appointment attendance, lab work, and satisfaction. The goal was to see if telemedicine is a practical way to overcome barriers to care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that telemedicine helps children with sickle cell disease get better access to care and reduces missed appointments.
- What could go wrong
- This was a small, early feasibility study with only 24 participants. It did not test a new treatment, so it cannot prove whether telemedicine improves health outcomes long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA, SICKLE CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University
Indianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a computer program tame sickle cell pain crises?
- New App-Based program aims to help teens with sickle cell disease stay out of the ER
- Sickle cell transplant study halted after just one patient
- New transplant approach offers hope for sickle cell patients without a perfect donor match
- Sickle cell hope: drug combo raises hemoglobin in early trial
- Could carbon monoxide be a medicine? new trial for sickle cell